Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

13

Number of overlapping holdings

11.0%

% of XBI's 119 holdings also in LFSC

46.4%

% of LFSC's 29 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus LFSC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in LFSC
Overlap
INSMED INC 2.7% 4.1% 2.7%
MADRIGAL PHARMACEUTICALS, INC. 2.3% 3.9% 2.3%
BLUEPRINT MEDICINES CORP. 2.2% 6.0% 2.2%
BRIDGEBIO PHARMA, INC. 1.8% 7.5% 1.8%
UNITED THERAPEUTICS CORP 2.6% 1.6% 1.6%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to LFSC
NATERA INC 2.8%
VERTEX PHARMACEUTICALS INC 2.7%
ALNYLAM PHARMACEUTICALS INC 2.7%
NEUROCRINE BIOSCIENCES INC 2.6%
GILEAD SCIENCES INC 2.5%
EXACT SCIENCES CORP 2.5%
AMGEN INC 2.5%
INCYTE CORP 2.4%
BIOGEN IDEC INC 2.3%
REGENERON PHARMACEUTICALS 2.3%
XBI Underweight Relative to LFSC
SOLENO THERAPEUTICS INC -7.6%
RADNET INC -6.2%
BRIDGEBIO PHARMA, INC. -5.8%
MERIT MEDICAL SYSTEMS INC -5.4%
TRANSMEDICS GROUP, INC. -5.1%
LIVANOVA PLC -4.7%
COLLEGIUM PHARMACEUTICAL, INC. -4.5%
TRAVERE THERAPEUTICS, INC. -4.2%
BLUEPRINT MEDICINES CORP. -3.9%
ALPHATEC HOLDINGS INC -3.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY